A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
Can inhaled corticosteroids alleviate early symptoms of COVID-19?
Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo
RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response
Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...
The 2021 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children
Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available
Research trainees are bridging the gap between science and the public
Two RI-MUHC research trainees share their experience as community outreach panelists
RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study
New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease
App-based HIV self-testing program leads to rapid detection of new infections and efficient connection to care
A unique new study shows that self-testing with the HIVSmart! program...